Antepartum obstetrical complications associated with obesity

Loralei L Thornburg1

  • 1Division of Maternal Fetal Medicine, University of Rochester School of Medicine, Rochester, NY 14642, USA. loralei_thornburg@urmc.rochester.edu

Seminars in Perinatology
|November 24, 2011
PubMed

Insights

Obesity significantly increases risks for serious pregnancy complications like pre-eclampsia and gestational diabetes. Early education and tailored prenatal care are crucial for improving outcomes for obese pregnant individuals.

Area of Science:

  • Obstetrics and Gynecology
  • Maternal-Fetal Medicine
  • Public Health

Background:

  • Obesity is a prevalent global health issue.
  • Obesity is a significant risk factor for numerous adverse maternal and fetal outcomes.
  • Existing literature highlights increased risks but often lacks comprehensive management strategies.

Purpose of the Study:

  • To outline the key obstetrical complications associated with maternal obesity.
  • To emphasize the need for specialized management considerations in prenatal care for obese gravidas.
  • To underscore the importance of patient education regarding pregnancy risks and management.

Main Methods:

  • Review of current literature on obesity in pregnancy.
  • Analysis of epidemiological data on obstetrical complications in obese populations.
  • Synthesis of clinical guidelines and expert recommendations for managing obese pregnancies.

Main Results:

  • Obesity is linked to higher rates of pre-eclampsia, gestational diabetes, indicated preterm birth, macrosomia, and stillbirth.
  • Underlying medical conditions in obese women can complicate pregnancy management.
  • Specific alterations in prenatal care protocols are recommended for obese gravidas.

Conclusions:

  • Maternal obesity necessitates a proactive and informed approach to prenatal care.
  • Educating women about risks before conception can empower them to seek appropriate care.
  • Optimizing management strategies can improve both maternal and infant health trajectories.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Intestinal Obstruction II: Pathophysiology01:07

Intestinal Obstruction II: Pathophysiology

Intestinal obstruction triggers a series of physiological responses, starting with gas and fluid accumulation in the bowel segment proximal to the obstruction, leading to distension. This distended intestine compresses the diaphragm, hindering lung expansion and potentially leading to reduced respiratory effort, atelectasis, and pneumonia.To overcome the blockage, the gut intensifies contractions, causing colicky abdominal pain, nausea, and vomiting, which reduces fluid and food intake and...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...